Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Thrombosis Therapy in German Cancer Patients

NCT01559883 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01559883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01559883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Thrombosis Therapy in German Cancer Patients
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2013
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, deep vein thrombosis, pulmonary embolism